Ceremedy is a Copenhagen-based biotech company focused on drug discovery for the treatment of CNS disorders. The company was founded in 2018 as a spin-off from the University of Copenhagen.

Ceremedy’s team strives to develop new treatments for CNS disorders by targeting an important brain protein with a broad range of implications for treating CNS disorders. Backed with medicinal chemistry, pharmacology and neuroscience experience, we aim to facilitate the full process from idea to drug candidate.

Ceremedy Aps

Org chart

Teams

Offices